In addition, cross-sectional comparison at baseline showed reduced activation of those marker genes in patients with severe COVID-19 compared to patients with mild COVID-19, which was attributed to the presence of IFN suppressors in multiple cell types. Here, IFNA1 is linked to COVID-19.